The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kim Dennis D since 2015.
This trader's CIK number is 1456750.
At the time of last reporting, Kim Dennis D was the Chief Medical Officer of Cymabay Therapeutics, Inc.. (stock ticker symbol CBAY).
Also see all insider trading activities at Cymabay Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | CBAY | 0 | $0 | 120,100 | $1,141,348 | 120,100 | $524,836 |
| 2022 | CBAY | 20,000 | $60,800 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ZFGN | 20,000 | $77,900 | 0 | $0 | 0 | $0 |
| 2015 | ZFGN | 0 | $0 | 40,000 | $1,600,000 | 40,000 | $62,799 |
1. Cymabay Therapeutics, Inc. (CBAY)
2. Larimar Therapeutics, Inc. (ZFGN)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-04-13 | CBAY | Sale | 7,781 | 8.98 | 69,881 |
| 2023-04-17 | CBAY | Option Ex | 112,219 | 4.37 | 490,397 |
| 2023-04-17 | CBAY | Sale | 112,219 | 9.54 | 1,070,569 |
| 2023-04-13 | CBAY | Option Ex | 7,781 | 4.37 | 34,002 |
| 2023-03-28 | CBAY | Sale | 100 | 8.98 | 898 |
| 2023-03-28 | CBAY | Option Ex | 100 | 4.37 | 437 |
| 2022-01-19 | CBAY | Buy | 20,000 | 3.04 | 60,800 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-07-11 | ZFGN | Buy | 10,000 | 3.39 | 33,900 |
| 2017-05-10 | ZFGN | Buy | 200 | 4.40 | 880 |
| 2017-05-11 | ZFGN | Buy | 9,800 | 4.40 | 43,120 |
| 2015-09-15 | ZFGN | Sale | 30,265 | 40.00 | 1,210,600 |
| 2015-09-17 | ZFGN | Option Ex | 9,142 | 1.57 | 14,352 |
| 2015-09-17 | ZFGN | Sale | 9,142 | 40.00 | 365,680 |
| 2015-09-15 | ZFGN | Option Ex | 30,265 | 1.57 | 47,516 |
| 2015-09-14 | ZFGN | Option Ex | 593 | 1.57 | 931 |
| 2015-09-14 | ZFGN | Sale | 593 | 40.00 | 23,720 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kim Dennis D (Chief Medical Officer of Cymabay Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.